La Jolla, CA, United States of America

Kim D Janda

USPTO Granted Patents = 35 

 

 

Average Co-Inventor Count = 2.0

ph-index = 11

Forward Citations = 867(Granted Patents)


Location History:

  • San Diego, CA (US) (1991 - 2016)
  • La Jolla, CA (US) (2002 - 2024)

Company Filing History:


Years Active: 1991-2024

Loading Chart...
Loading Chart...
Loading Chart...
35 patents (USPTO):Explore Patents

Title: Innovations by Kim D. Janda: Pioneering Advances in Cancer Treatment and Substance Abuse Prevention

Introduction: Kim D. Janda, a distinguished inventor based in La Jolla, California, has made remarkable contributions to the fields of medical science and pharmacology. With a notable portfolio of 35 patents, his work focuses on groundbreaking therapies, including cancer treatments and vaccine development. His innovative approaches reflect a deep commitment to addressing critical health issues through scientific research and collaboration.

Latest Patents: Among his latest patents, Janda has developed a pharmacophore for TRAIL induction, which involves the use of imidazolinopyrimidinone compounds. These compounds have shown the ability to induce TRAIL gene expression in macrophages, showcasing potential for treating various cancers. Another significant patent is for an improved heroin conjugate vaccine. This vaccine development involved extensive exploration of twenty different formulations with varying carrier proteins and adjuvants. Notably, the formulations that incorporated Toll-like receptor 3 (TLR3) and TLR9 agonists with alum demonstrated strong anti-heroin antibody responses, providing critical protection against lethal doses of heroin while ensuring stability even after long-term storage.

Career Highlights: Kim D. Janda has made significant strides throughout his career, contributing to esteemed institutions such as The Scripps Research Institute and the Scripps Clinic and Research Foundation. His research not only showcases his innovative capabilities but also emphasizes his dedication to advancing public health through scientific exploration.

Collaborations: Janda’s work has been enriched by collaborating with notable colleagues, including Richard A. Lerner and Peter Wirsching. These partnerships have played a vital role in fostering innovative solutions in his research endeavors, advancing both scientific understanding and practical applications in health.

Conclusion: Kim D. Janda’s innovative contributions, particularly in the realms of cancer treatment and vaccine development, underline the significant impact of his research on public health. With a robust collection of patents and collaborative efforts, he exemplifies the role of inventors in pioneering advancements to tackle complex health challenges. His work continues to inspire future innovations that may lead to transformative therapies and preventive strategies in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…